More than 160 speakers and 2000 registrants from 600 organizations and 30 countries are coming to Boston for the annual World Medical Innovation Forum (WMIF) April 8-10. Hosted by Partners HealthCare Innovation, the business development and commercialization unit of PHS, this year’s Forum features industry CEOs, our Harvard faculty, investors and technologists exploring the impact of artificial intelligence (AI) on clinical care. The Forum covers AI opportunities and impact on disease areas ranging from cancer care, cardiovascular and neuro, to mental health and the opioid crisis.

The Forum also features provider AI strategies, 50 AI medical application use cases, and clinical and technology visionaries imagining medicine in 2054. CEOs and top executives from Bayer, BMS, GE Healthcare, Nuance, Nvidia, Amgen, Biogen and Walters Kluwer are featured, along with Deepak Chopra, MD and former Secretary of Defense Ash Carter providing insights on healthcare and the power of AI.

The event wraps with the annual Innovator’s Dinner, celebrating excellence in innovation and the accomplishments of Partners-wide investigators and their discoveries in 2018.

This year’s Forum co-chairs are Anne Klibanski, MD, Interim President and CEO, Partners HealthCare System, and Gregg Meyer, MD, Chief Clinical Officer, Partners HealthCare System. The Forum is a global conference established five years ago to respond to the intensifying transformation of health care and its impact on innovation. It is rooted in the belief that no matter the magnitude of that change, the center of health care needs to be a shared, fundamental commitment to collaborative innovation – industry and academia working together to improve patient lives. To find out more about the Forum, speakers and agenda, and to register, visit https://worldmedicalinnovation.org.